HIGH-DOSE CHEMOTHERAPY WITH ABMT IN SOFT-TISSUE SARCOMAS - A REPORT OF 22 CASES

被引:0
|
作者
DUMONTET, C [1 ]
BIRON, P [1 ]
BOUFFET, E [1 ]
BLAY, JY [1 ]
MECKENSTOCK, R [1 ]
CHAUVIN, F [1 ]
PHILIP, I [1 ]
CLAVEL, M [1 ]
BRUNATMENTIGNY, M [1 ]
PHILIP, T [1 ]
机构
[1] CTR LEON BERARD,28 RUE LAENNEC,F-60373 LYON,FRANCE
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Twenty-two patients with locally advanced or metastatic soft tissue sarcomas received high dose chemotherapy with autologous bone marrow graft. Eleven patients receiving melphalan also received fractionated total body irradiation. Six patients (four in CR and two in PR) were intensified after first line therapy. Thirteen patients were grafted after chemosensitive relapse: seven in second CR, one in third CR, one in first PR, three in second PR and one in fourth PR. Three patients with primary refractory disease were intensified. The overall response rate in 66% in nine evaluable patients. The overall median survival and disease-free survival were 19 and 15 months, respectively. The actuarial survival rates at 2 and 5 years were 40% and 32% respectively. There was one treatment-related death due to infection. We conclude that high dose chemotherapy is feasible and provides reasonable response rates in patients with advanced soft tissue sarcomas.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 50 条
  • [31] CHEMOTHERAPY OF ADVANCED SOFT-TISSUE SARCOMAS
    ANTMAN, KH
    ELIAS, AD
    [J]. SEMINARS IN SURGICAL ONCOLOGY, 1988, 4 (01): : 53 - 58
  • [32] RADIOTHERAPY AND CHEMOTHERAPY OF SOFT-TISSUE SARCOMAS
    RINGBORG, U
    [J]. ACTA ORTHOPAEDICA SCANDINAVICA, 1981, 52 (04): : 455 - 455
  • [33] SOFT-TISSUE SARCOMAS IN ADULTS - A REPORT OF 3 CASES OF MYXOSARCOMA
    KREMER, P
    WENDLING, D
    RANFAING, E
    BOSSET, JF
    GUIDET, M
    [J]. SEMAINE DES HOPITAUX, 1992, 68 (13): : 357 - 361
  • [34] HIGH-DOSE IFOSFAMIDE - CIRCUMVENTION OF RESISTANCE TO STANDARD-DOSE IFOSFAMIDE IN ADVANCED SOFT-TISSUE SARCOMAS
    LECESNE, A
    ANTOINE, E
    SPIELMANN, M
    LECHEVALIER, T
    BRAIN, E
    TOUSSAINT, C
    JANIN, N
    KAYITALIRE, L
    FONTAINE, F
    GENIN, J
    VANEL, D
    CONTESSO, G
    TURSZ, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) : 1600 - 1608
  • [35] HIGH-DOSE EPIRUBICIN-CISPLATIN CHEMOTHERAPY FOR ADVANCED SOFT-TISSUE SARCOMA
    JELIC, S
    VULETIC, L
    MILANOVIC, N
    TOMASEVIC, Z
    KOVCIN, V
    [J]. TUMORI JOURNAL, 1990, 76 (05): : 467 - 471
  • [36] Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
    Leyvraz, S.
    Herrmann, R.
    Guillou, L.
    Honegger, H. P.
    Christinat, A.
    Fey, M. F.
    Sessa, C.
    Wernli, M.
    Cerny, T.
    Dietrich, D.
    Pestalozzi, B.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (10) : 1342 - 1347
  • [37] Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
    S Leyvraz
    R Herrmann
    L Guillou
    H P Honegger
    A Christinat
    M F Fey
    C Sessa
    M Wernli
    T Cerny
    D Dietrich
    B Pestalozzi
    [J]. British Journal of Cancer, 2006, 95 : 1342 - 1347
  • [38] SIMULTANEOUS RADIOTHERAPY AND CHEMOTHERAPY OF SOFT-TISSUE SARCOMAS
    PAPE, H
    ZAMBOGLOU, N
    FURST, G
    SCHMITT, G
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1988, 9 : 31 - 34
  • [39] CHEMOTHERAPY OF ADVANCED SARCOMAS OF BONE AND SOFT-TISSUE
    ANTMAN, KH
    [J]. SEMINARS IN ONCOLOGY, 1992, 19 (06) : 13 - 22
  • [40] INTRAARTERIAL INDUCTION CHEMOTHERAPY FOR SOFT-TISSUE SARCOMAS
    AZZARELLI, A
    QUAGLIUOLO, V
    FISSI, S
    CASALI, P
    GARBUGLIA, A
    BIGNAMI, P
    SANTORO, A
    ANDREOLA, S
    GENNARI, L
    [J]. ANNALS OF ONCOLOGY, 1992, 3 : S67 - S70